Accuray , Nasdaq: ARAY
Offers an FDA-approved robotic radiosurgery system to treat solid tumors.
Industry: Health Care
First Day Return: +58.2%
Industry: Health Care
ARAY
Offers an FDA-approved robotic radiosurgery system to treat solid tumors.
| IPO Data | |
|---|---|
| IPO File Date | 11/13/2006 |
| Offer Price | $18.00 |
| Price Range $14.00 - $16.00 | |
| Offer Shares (mm) | 16.0 |
| Deal Size ($mm) | $288 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 02/07/2007 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $288 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Sunnyvale, CA, United States |
| Founded | 1992 |
| Employees at IPO | 458 |
| Website www.accuray.com | |
Accuray (ARAY) Performance
